A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)
Keywords: Nasopharyngeal cancer; Cisplatin; Weekly docetaxel;